Skip to main content
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging 13/2016

10.06.2016 | Original Article

Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure

verfasst von: Giuseppe Rengo, Gennaro Pagano, Dino Franco Vitale, Roberto Formisano, Klara Komici, Laura Petraglia, Valentina Parisi, Grazia Daniela Femminella, Claudio de Lucia, Stefania Paolillo, Alessandro Cannavo, Emilio Attena, Teresa Pellegrino, Santo Dellegrottaglie, Alessia Memmi, Bruno Trimarco, Alberto Cuocolo, Pasquale Perrone Filardi, Dario Leosco, Nicola Ferrara

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 13/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Sympathetic nervous system (SNS) hyperactivity is a salient characteristic of chronic heart failure (HF) and contributes to the progression of the disease. Iodine-123 meta-iodobenzylguanidine (123I-mIBG) imaging has been successfully used to assess cardiac SNS activity in HF patients and to predict prognosis. Importantly, SNS hyperactivity characterizes also physiological ageing, and there is conflicting evidence on cardiac 123I-mIBG uptake in healthy elderly subjects compared to adults. However, little data are available on the impact of ageing on cardiac sympathetic nerve activity assessed by 123I-mIBG scintigraphy, in patients with HF.

Methods and results

We studied 180 HF patients (age = 66.1 ± 10.5 years [yrs]), left ventricular ejection fraction (LVEF = 30.6 ± 6.3 %) undergoing cardiac 123I-mIBG imaging. Early and late heart to mediastinum (H/M) ratios and washout rate were calculated in all patients. Demographic, clinical, and echocardiographic data were also collected. Our study population consisted of 53 patients aged >75 years (age = 77.7 ± 4.0 year), 67 patients aged 62–72 years (age = 67.9 ± 3.2 years) and 60 patients aged ≤61 year (age = 53.9 ± 5.6 years). In elderly patients, both early and late H/M ratios were significantly lower compared to younger patients (p < 0.05). By multivariate analysis, H/M ratios (both early and late) and washout rate were significantly correlated with LVEF and age.

Conclusions

Our data indicate that, in a population of HF patients, there is an independent age-related effect on cardiac SNS innervation assessed by 123I-mIBG imaging. This finding suggests that cardiac 123I-mIBG uptake in patients with HF might be affected by patient age.
Literatur
1.
Zurück zum Zitat Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375–85.CrossRefPubMed Floras JS. Sympathetic nervous system activation in human heart failure: clinical implications of an updated model. J Am Coll Cardiol. 2009;54:375–85.CrossRefPubMed
2.
Zurück zum Zitat Lymperopoulos A, Rengo G, Koch WJ. The adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res Circ Res. 2013;113:739–53.CrossRefPubMed Lymperopoulos A, Rengo G, Koch WJ. The adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res Circ Res. 2013;113:739–53.CrossRefPubMed
3.
Zurück zum Zitat Rengo G, Lymperopoulos A, Koch WJ. Future g protein-coupled receptor targets for treatment of heart failure. Curr Treat Options Cardiovasc Med. 2009;11:328–38.CrossRefPubMed Rengo G, Lymperopoulos A, Koch WJ. Future g protein-coupled receptor targets for treatment of heart failure. Curr Treat Options Cardiovasc Med. 2009;11:328–38.CrossRefPubMed
4.
Zurück zum Zitat Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease. Physiologic basis and prognostic implications. J Am Coll Cardiol. 2008;51:1725–33.CrossRefPubMed Lahiri MK, Kannankeril PJ, Goldberger JJ. Assessment of autonomic function in cardiovascular disease. Physiologic basis and prognostic implications. J Am Coll Cardiol. 2008;51:1725–33.CrossRefPubMed
5.
Zurück zum Zitat Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292–9.CrossRefPubMed Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFT. Eur Heart J. 2004;25:292–9.CrossRefPubMed
6.
Zurück zum Zitat Tsutamoto T, Nishiyama K, Sakai H, Tanaka T, Fujii M, Yamamoto T, et al. Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. Eur J Heart Fail. 2008;10:1208–14.CrossRefPubMed Tsutamoto T, Nishiyama K, Sakai H, Tanaka T, Fujii M, Yamamoto T, et al. Transcardiac increase in norepinephrine and prognosis in patients with chronic heart failure. Eur J Heart Fail. 2008;10:1208–14.CrossRefPubMed
7.
Zurück zum Zitat Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999;33:1203–7.CrossRefPubMed Fauchier L, Babuty D, Cosnay P, Fauchier JP. Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 1999;33:1203–7.CrossRefPubMed
8.
Zurück zum Zitat La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.CrossRefPubMed La Rovere MT, Pinna GD, Maestri R, Mortara A, Capomolla S, Febo O, et al. Short-term heart rate variability strongly predicts sudden cardiac death in chronic heart failure patients. Circulation. 2003;107:565–70.CrossRefPubMed
9.
Zurück zum Zitat McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefPubMed McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail. 2012;14:803–69.CrossRefPubMed
10.
Zurück zum Zitat Carrio I. Cardiac neurotransmission imaging. J Nucl Med. 2001;42:1062–76.PubMed Carrio I. Cardiac neurotransmission imaging. J Nucl Med. 2001;42:1062–76.PubMed
11.
Zurück zum Zitat Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging. 2007;34:939–50.CrossRefPubMed Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging. 2007;34:939–50.CrossRefPubMed
12.
Zurück zum Zitat Perrone-Filardi P, Paolillo S, Dellegrottaglie S, Gargiulo P, Savarese G, Marciano C, et al. Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. Heart. 2011;97:1828–33.CrossRefPubMed Perrone-Filardi P, Paolillo S, Dellegrottaglie S, Gargiulo P, Savarese G, Marciano C, et al. Assessment of cardiac sympathetic activity by MIBG imaging in patients with heart failure: a clinical appraisal. Heart. 2011;97:1828–33.CrossRefPubMed
13.
Zurück zum Zitat Agostini D, Verberne HJ, Hamon M, Jacobson AF, Manrique AQ. Cardiac 123I-MIBG scintigraphy in heart failure. J Nucl Med Mol Imaging. 2008;52:369–77. Agostini D, Verberne HJ, Hamon M, Jacobson AF, Manrique AQ. Cardiac 123I-MIBG scintigraphy in heart failure. J Nucl Med Mol Imaging. 2008;52:369–77.
14.
Zurück zum Zitat Chirumamilla A, Travin MI. Cardiac applications of 123I-mIBG imaging. Semin Nucl Med. 2011;41:374–87.CrossRefPubMed Chirumamilla A, Travin MI. Cardiac applications of 123I-mIBG imaging. Semin Nucl Med. 2011;41:374–87.CrossRefPubMed
15.
Zurück zum Zitat Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 metaiodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol. 2010;55:2212–21.CrossRefPubMed Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 metaiodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView myocardial imaging for risk evaluation in heart failure) study. J Am Coll Cardiol. 2010;55:2212–21.CrossRefPubMed
16.
Zurück zum Zitat Docherty JR. Age-related changes in adrenergic neuroeffector transmission. Auton Neurosci. 2002;96:8–12.CrossRefPubMed Docherty JR. Age-related changes in adrenergic neuroeffector transmission. Auton Neurosci. 2002;96:8–12.CrossRefPubMed
17.
Zurück zum Zitat Ferrara N, Komici K, Corbi G, Pagano G, Furgi G, Rengo C, et al. β-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol. 2014;4:396.CrossRefPubMedPubMedCentral Ferrara N, Komici K, Corbi G, Pagano G, Furgi G, Rengo C, et al. β-adrenergic receptor responsiveness in aging heart and clinical implications. Front Physiol. 2014;4:396.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, et al. Aging effects on human sympathetic neuronal function. Am J Physiol. 1995;268:R278–85.PubMed Esler MD, Turner AG, Kaye DM, Thompson JM, Kingwell BA, Morris M, et al. Aging effects on human sympathetic neuronal function. Am J Physiol. 1995;268:R278–85.PubMed
19.
Zurück zum Zitat Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature. 1976;261:333–5.CrossRefPubMed Ziegler MG, Lake CR, Kopin IJ. Plasma noradrenaline increases with age. Nature. 1976;261:333–5.CrossRefPubMed
20.
Zurück zum Zitat Ferrari AU. Modifications of the cardiovascular system with aging. Am J Geriatr Cardiol. 2002;11:30–3.CrossRefPubMed Ferrari AU. Modifications of the cardiovascular system with aging. Am J Geriatr Cardiol. 2002;11:30–3.CrossRefPubMed
21.
Zurück zum Zitat Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, et al. Decreased catecholamine sensitivity and b-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205–11.CrossRefPubMed Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, et al. Decreased catecholamine sensitivity and b-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982;307:205–11.CrossRefPubMed
22.
Zurück zum Zitat Davies CH, Ferrara N, Harding SE. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovasc Res. 1996;31:152–6.PubMed Davies CH, Ferrara N, Harding SE. Beta-adrenoceptor function changes with age of subject in myocytes from non-failing human ventricle. Cardiovasc Res. 1996;31:152–6.PubMed
23.
Zurück zum Zitat Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol. 1995;2:126–32.PubMed Estorch M, Carrio I, Berna L, Lopez-Pousa J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol. 1995;2:126–32.PubMed
24.
Zurück zum Zitat Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med. 1995;36:969–74.PubMed Tsuchimochi S, Tamaki N, Tadamura E, Kawamoto M, Fujita T, Yonekura Y, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med. 1995;36:969–74.PubMed
25.
Zurück zum Zitat Chen W, Botvinick EH, Alavi A, Zhang Y, Yang S, Perini R, et al. Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging. J Nucl Cardiol. 2008;15:73–9.CrossRefPubMed Chen W, Botvinick EH, Alavi A, Zhang Y, Yang S, Perini R, et al. Age-related decrease in cardiopulmonary adrenergic neuronal function in children as assessed by I-123 metaiodobenzylguanidine imaging. J Nucl Cardiol. 2008;15:73–9.CrossRefPubMed
26.
Zurück zum Zitat Jacobson AF, Chen J, Verdes L, Folks RD, Manatunga DN, Garcia EV. Impact of age on myocardial uptake of 123I-mIBG in older adult subjects without coronary heart disease. J Nucl Cardiol. 2013;20:406–14.CrossRefPubMed Jacobson AF, Chen J, Verdes L, Folks RD, Manatunga DN, Garcia EV. Impact of age on myocardial uptake of 123I-mIBG in older adult subjects without coronary heart disease. J Nucl Cardiol. 2013;20:406–14.CrossRefPubMed
27.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.CrossRefPubMed Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79–108.CrossRefPubMed
28.
Zurück zum Zitat Paolillo S, Rengo G, Pagano G, Pellegrino T, Savarese G, Femminella GD, et al. Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care. 2013;36:2395–401.CrossRefPubMedPubMedCentral Paolillo S, Rengo G, Pagano G, Pellegrino T, Savarese G, Femminella GD, et al. Impact of diabetes on cardiac sympathetic innervation in patients with heart failure: a 123I meta-iodobenzylguanidine (123I MIBG) scintigraphic study. Diabetes Care. 2013;36:2395–401.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Pellegrino T, Petretta M, De Luca S, Paolillo S, Boemio A, Carotenuto R, et al. Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging. 2013;40:1549–57.CrossRefPubMed Pellegrino T, Petretta M, De Luca S, Paolillo S, Boemio A, Carotenuto R, et al. Observer reproducibility of results from a low-dose 123I-metaiodobenzylguanidine cardiac imaging protocol in patients with heart failure. Eur J Nucl Med Mol Imaging. 2013;40:1549–57.CrossRefPubMed
30.
Zurück zum Zitat Royston P, Sauerbrei W. Multivariate model building. A pragmatic approach to regression analysis based on fractional polynomials for modeling continuous variables. Chichester: Wiley; 2008. Royston P, Sauerbrei W. Multivariate model building. A pragmatic approach to regression analysis based on fractional polynomials for modeling continuous variables. Chichester: Wiley; 2008.
31.
Zurück zum Zitat Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964–74.CrossRefPubMed Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol. 1999;28:964–74.CrossRefPubMed
32.
Zurück zum Zitat Royston P, Sauerbrei W. Bootstrap assessment of the stability of multivariable models. Stata J. 2009;9:547–70. Royston P, Sauerbrei W. Bootstrap assessment of the stability of multivariable models. Stata J. 2009;9:547–70.
33.
Zurück zum Zitat Shorrocks AF. Decomposition procedures for distributional analysis: a unified framework based on the Shapley value. J Econ Inequal. 2013;11:99–126.CrossRef Shorrocks AF. Decomposition procedures for distributional analysis: a unified framework based on the Shapley value. J Econ Inequal. 2013;11:99–126.CrossRef
34.
Zurück zum Zitat Kutner M, Nachtsheim C, Neter J. MP. Applied linear regression models-revised edition with student CD. 4th ed. NY: McGraw Hill/Irwin; 2004. Kutner M, Nachtsheim C, Neter J. MP. Applied linear regression models-revised edition with student CD. 4th ed. NY: McGraw Hill/Irwin; 2004.
35.
Zurück zum Zitat Rengo F, Leosco D, Iacovoni A, Rengo G, Golino L, Borgia F, et al. Epidemiology and risk factors for heart failure in the elderly. Ital Heart J. 2004;5 Suppl 10:9S–16.PubMed Rengo F, Leosco D, Iacovoni A, Rengo G, Golino L, Borgia F, et al. Epidemiology and risk factors for heart failure in the elderly. Ital Heart J. 2004;5 Suppl 10:9S–16.PubMed
36.
Zurück zum Zitat Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147–59.CrossRefPubMed Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J. 2008;29:1147–59.CrossRefPubMed
37.
Zurück zum Zitat Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. JACC. 2009;53:426–35.CrossRefPubMed Tamaki S, Yamada T, Okuyama Y, Morita T, Sanada S, Tsukamoto Y, et al. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion. JACC. 2009;53:426–35.CrossRefPubMed
38.
Zurück zum Zitat Chizzola PR, Gonçalves de Freitas HF, Mansur JA, Meneghetti JC, Bocchi EA. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. Int J Cardiol. 2006;106:29–34.CrossRefPubMed Chizzola PR, Gonçalves de Freitas HF, Mansur JA, Meneghetti JC, Bocchi EA. The effect of beta-adrenergic receptor antagonism in cardiac sympathetic neuronal remodeling in patients with heart failure. Int J Cardiol. 2006;106:29–34.CrossRefPubMed
39.
Zurück zum Zitat Sakamaki F, Satoh T, Nagaya N, Kyotani S, Nakanishi N, Ishida Y. Abnormality of left ventricular sympathetic nervous function assessed by (123)I-metaiodobenzylguanidine imaging in patients with COPD. Chest. 1999;116:1575–81.CrossRefPubMed Sakamaki F, Satoh T, Nagaya N, Kyotani S, Nakanishi N, Ishida Y. Abnormality of left ventricular sympathetic nervous function assessed by (123)I-metaiodobenzylguanidine imaging in patients with COPD. Chest. 1999;116:1575–81.CrossRefPubMed
40.
Zurück zum Zitat Steinhagen-Thiessen E, Bramlage P, Lösch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2008;7:31.CrossRefPubMedPubMedCentral Steinhagen-Thiessen E, Bramlage P, Lösch C, Hauner H, Schunkert H, Vogt A, et al. Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol. 2008;7:31.CrossRefPubMedPubMedCentral
41.
Zurück zum Zitat Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging. 2014;41:1673.CrossRefPubMedPubMedCentral Nakajima K, Nakata T, Yamada T, Yamashina S, Momose M, Kasama S, et al. A prediction model for 5-year cardiac mortality in patients with chronic heart failure using 123I-metaiodobenzylguanidine imaging. Eur J Nucl Med Mol Imaging. 2014;41:1673.CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging. 2014;15:996–1003.CrossRefPubMed Verschure DO, Veltman CE, Manrique A, Somsen GA, Koutelou M, Katsikis A, et al. For what endpoint does myocardial 123I-MIBG scintigraphy have the greatest prognostic value in patients with chronic heart failure? Results of a pooled individual patient data meta-analysis. Eur Heart J Cardiovasc Imaging. 2014;15:996–1003.CrossRefPubMed
43.
Zurück zum Zitat Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6:772–84.CrossRefPubMed Nakata T, Nakajima K, Yamashina S, Yamada T, Momose M, Kasama S, et al. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure. JACC Cardiovasc Imaging. 2013;6:772–84.CrossRefPubMed
44.
Zurück zum Zitat Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol. 2006;13:251–60.CrossRefPubMed Chen J, Garcia EV, Galt JR, Folks RD, Carrio I. Optimized acquisition and processing protocols for I-123 cardiac SPECT imaging. J Nucl Cardiol. 2006;13:251–60.CrossRefPubMed
Metadaten
Titel
Impact of aging on cardiac sympathetic innervation measured by 123I-mIBG imaging in patients with systolic heart failure
verfasst von
Giuseppe Rengo
Gennaro Pagano
Dino Franco Vitale
Roberto Formisano
Klara Komici
Laura Petraglia
Valentina Parisi
Grazia Daniela Femminella
Claudio de Lucia
Stefania Paolillo
Alessandro Cannavo
Emilio Attena
Teresa Pellegrino
Santo Dellegrottaglie
Alessia Memmi
Bruno Trimarco
Alberto Cuocolo
Pasquale Perrone Filardi
Dario Leosco
Nicola Ferrara
Publikationsdatum
10.06.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 13/2016
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-016-3432-3

Weitere Artikel der Ausgabe 13/2016

European Journal of Nuclear Medicine and Molecular Imaging 13/2016 Zur Ausgabe